Recombinant Anti-CD19m-CD3 Antibody Injection (A-319)

anti-CD19×anti-CD3 bispecific antibody · Shanxi Bethune Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Anti-CD19m-CD3 Antibody Injection (A-319), covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319) [NA]

See pricing